Double-Fistin' Jade-Lizards on $EXASFIRST ONE:
7/18 EXPIRATION
+1 $57.5 call
-1 $55 call
-1 $52.5 put
$49.1 BE ($340 credit)
SECOND ONE:
8/22 EXPIRATION
+1 $61 call
-1 $60 call
-$ 51 put
$48 BE ($300 credit)
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.600 EUR
−993.85 M EUR
2.67 B EUR
186.73 M
About Exact Sciences Corporation
Sector
Industry
CEO
Kevin T. Conroy
Website
Headquarters
Madison
Founded
1995
ISIN
US30063P1057
FIGI
BBG01TNXQFV1
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Related stocks
Exact Sciences: Downtrend May Be BrokenExact Sciences jumped on strong earnings two weeks ago, and some traders may think the oncology stock has further upside.
The first pattern on today’s chart is the bullish price gap on May 2 after results beat estimates. Prices apparently broke a falling trendline in the process.
EXAS then consoli
$EXASGreen: Entry Point
Blue: Start of Week
Red: End of Week
Thumbs Up: Trade Available for Week
Numbers: Price Targets
*For share traders only. Not meant for options.
EXAS a Bullish OutlookAs I predicted before, I had a 100% success rate. Let's consider a long position based on the current technical indicators.
Trend Line: We have a yellow trend line where the price bounced in 2016 and 2022. We are now approaching this trend line again.
Bat Pattern: The bat pattern indicates that poi
Exact Sciences: Anticipating a Market Correction Amidst OverbougExact Sciences is exhibiting bullish tendencies at present, but it's critical to anticipate a substantial correction upon touching, or descending below, the 0.618 Fibonacci retracement level. The stock is likely to retreat to around $70, a significant support level we've observed. The patterns in pl
Exact Sciences (EXAS) - Continuation of the DowntrendBased on my previous technical analysis where Exact Sciences exhibited bullish tendencies but warned of a possible substantial correction around the $70 level, we now find ourselves at a critical junction. Two possible scenarios could unfold from here: a bearish three drives pattern leading to a bou
ABC Correction looks to be over for EXASCorrection could now be over @ 62% retrace.
Looking for a move up to the upper trend line into 2027 based on previous cycles.
+ Momentum divergence at the c wave low suggests energy is building for the next move higher.
Trendchanges and its author are not registered financial advisors. Every
Exact Sciences Corporation Fundamentally The Company have a really good quarterly results and is looking cheap at this price. Technically we can see buying pressure from good area of support. Price might go as high as 84.50/85.50 $ before next quarterly results.
EXAS - Amazing symmetry
If you want to know where price is going to be, look for the history. Will this break out of this range and head higher or flush below?
if it can close above 65 this week, I would keep an eye on it above 68. It moves quickly so a news could push this over/under.
Long via commons and optio
Exact sciences corp Exact Sciences is a biotech stock that is overpriced.
It's time to sell
We touched 3 times the resistance line of a rising wedge pattern, impulsive wave pattern, and RSI 71 weekly overbought zone, the Q2 doesn't seem good.
A leg down to 60$ retesting 69$ which is the resistance line of a rising
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
EXAS4806408
Exact Sciences Corporation 0.375% 15-MAR-2027Yield to maturity
—
Maturity date
Mar 15, 2027
EXAS4957195
Exact Sciences Corporation 0.375% 01-MAR-2028Yield to maturity
—
Maturity date
Mar 1, 2028
EXAS5793007
Exact Sciences Corporation 1.75% 15-APR-2031Yield to maturity
—
Maturity date
Apr 15, 2031
EXAS5549793
Exact Sciences Corporation 2.0% 01-MAR-2030Yield to maturity
—
Maturity date
Mar 1, 2030
See all 1EXAS bonds
Curated watchlists where 1EXAS is featured.
Frequently Asked Questions
The current price of 1EXAS is 45.640 EUR — it has decreased by −1.25% in the past 24 hours. Watch Exact Sciences Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Exact Sciences Corporation stocks are traded under the ticker 1EXAS.
1EXAS stock has risen by 1.00% compared to the previous week, the month change is a 14.49% rise, over the last year Exact Sciences Corporation has showed a 15.93% increase.
We've gathered analysts' opinions on Exact Sciences Corporation future price: according to them, 1EXAS price has a max estimate of 72.90 EUR and a min estimate of 45.45 EUR. Watch 1EXAS chart and read a more detailed Exact Sciences Corporation stock forecast: see what analysts think of Exact Sciences Corporation and suggest that you do with its stocks.
1EXAS reached its all-time high on May 16, 2025 with the price of 51.230 EUR, and its all-time low was 35.200 EUR and was reached on Aug 11, 2025. View more price dynamics on 1EXAS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1EXAS stock is 1.27% volatile and has beta coefficient of 0.34. Track Exact Sciences Corporation stock price on the chart and check out the list of the most volatile stocks — is Exact Sciences Corporation there?
Today Exact Sciences Corporation has the market capitalization of 8.70 B, it has decreased by −7.11% over the last week.
Yes, you can track Exact Sciences Corporation financials in yearly and quarterly reports right on TradingView.
Exact Sciences Corporation is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
1EXAS earnings for the last quarter are −0.01 EUR per share, whereas the estimation was −0.11 EUR resulting in a 92.08% surprise. The estimated earnings for the next quarter are −0.01 EUR per share. See more details about Exact Sciences Corporation earnings.
Exact Sciences Corporation revenue for the last quarter amounts to 688.53 M EUR, despite the estimated figure of 656.86 M EUR. In the next quarter, revenue is expected to reach 694.61 M EUR.
1EXAS net income for the last quarter is −1.01 M EUR, while the quarter before that showed −93.56 M EUR of net income which accounts for 98.92% change. Track more Exact Sciences Corporation financial stats to get the full picture.
No, 1EXAS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 28, 2025, the company has 7 K employees. See our rating of the largest employees — is Exact Sciences Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Exact Sciences Corporation EBITDA is 43.37 M EUR, and current EBITDA margin is 0.84%. See more stats in Exact Sciences Corporation financial statements.
Like other stocks, 1EXAS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Exact Sciences Corporation stock right from TradingView charts — choose your broker and connect to your account.